Incorporation of GSTA1 Genetic Variations into a Population Pharmacokinetic Model for IV Busulfan in Pediatric Hematopoietic Stem Cell Transplantation Publication Incorporation of GSTA1 Genetic Variations into a Population Pharmacokinetic Model for IV Busulfan in Pediatric Hematopoietic Stem Cell Transplantation CertaraFebruary 22, 2018
Surveying the Lay of the Land for Modeling & Simulation for Global Regulatory Submissions Blog Surveying the Lay of the Land for Modeling & Simulation for Global Regulatory Submissions Analogous to how a geologist surveys the “lay of the land” to determine if oil…CertaraFebruary 16, 2018
Model-informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor Publication Model-informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor CertaraFebruary 15, 2018
Modeling and Simulation of Bone Mineral Density in Japanese Osteoporosis Patients Treated with Zoledronic Acid Using Tartrate-resistant Acid Phosphatase 5b, a Bone Resorption Marker Publication Modeling and Simulation of Bone Mineral Density in Japanese Osteoporosis Patients Treated with Zoledronic Acid Using Tartrate-resistant Acid Phosphatase 5b, a Bone Resorption Marker CertaraFebruary 8, 2018
Using PBPK Models to Assess Fetal Drug Exposure Blog Using PBPK Models to Assess Fetal Drug Exposure The tragedy of thalidomide provides a cautionary tale about the potential for birth defects resulting…CertaraJanuary 19, 2018
Treatment of Adult Chronic Indeterminate Chagas Disease with Benznidazole and Three E1224 Dosing Regimens: A Proof-of-concept, Randomised, Placebo-controlled Trial Publication Treatment of Adult Chronic Indeterminate Chagas Disease with Benznidazole and Three E1224 Dosing Regimens: A Proof-of-concept, Randomised, Placebo-controlled Trial CertaraJanuary 15, 2018
Best Practices for Developing High Quality, On Time Submissions White Paper Best Practices for Developing High Quality, On Time Submissions Sponsors often struggle with submission planning. Read this white paper to learn how to develop…CertaraJanuary 8, 2018
Model-informed Drug Development for Malaria Therapeutics Publication Model-informed Drug Development for Malaria Therapeutics CertaraJanuary 6, 2018
How to Perform Level C IVIVC in Phoenix On-Demand Webinar How to Perform Level C IVIVC in Phoenix Step-by-step guidance for Level C IVIVC studies.CertaraDecember 13, 2017
Prediction of Olanzapine Exposure in Individual Patients Using Physiologically-based Pharmacokinetic Modeling and Simulation Publication Prediction of Olanzapine Exposure in Individual Patients Using Physiologically-based Pharmacokinetic Modeling and Simulation CertaraNovember 30, 2017